Skip to content
Companies

RNAV8 BIO

Machine learning design of mRNA for higher expression

Raised to date

$2M

of $3M offered across 1 Form D filing

Still open
$986K
Investors
42
Last filed
Mar 17, 2025

About

RNAV8 Bio, Inc. is an innovative biotechnology company dedicated to enhancing the efficacy of mRNA therapeutics. By harnessing advanced technologies like machine learning and artificial intelligence, RNAV8 aims to revolutionize the field of mRNA-based drug development for a wide array of diseases.

RNAV8 stands out due to its unique integration of rational design with cutting-edge machine learning techniques, enhancing mRNA expression for more effective therapies.

Funding

  • Option to acquireFiled Mar 17, 2025Form D/A
    $2M/ $3M

Product

mRNA Engineering and Design Platform

mRNA Therapeutics

The mRNA engineering and design platform developed by RNAV8 utilizes machine learning and artificial intelligence to optimize mRNA functions. This platform is designed to improve the expression levels of mRNA, thus enhancing the potency and specificity of mRNA-based therapeutics.

  • Integration of rational design techniques
  • Use of advanced machine learning algorithms
  • Capability to tailor mRNA functions for various applications

Built for

Pharmaceutical and biotechnology companies

People on file